Aleafia Health Inc. (OTCMKTS:ALEAF) Enters Agreement With BLLDR and Partnership With Unifor

Aleafia Health Inc. (OTCMKTS:ALEAF) has signed a definitive supply deal with cannabis brand house Robes Cannabis Inc. and announced a long term partnership with Unifor. Through the partnership, Unifor will seek to offer access for its members to medical marijuana coverage.

Unifor enters partnership with Aleafia Health

Unifor National President Jerry Dias indicated that the partnership is a massive milestone for the company whereby a medical cannabis company and a union are coming together to offer dedicated support via medical cannabis clinics nationwide. He said that through the agreement they will be able to challenge. He added that the partnership with Aleafia will allow the union to fight the opiate crisis in Canada and improve patients’ lives. Most importantly Unifor will engage local unions to propose and recommend insurance coverage in collective bargaining agreements for medical cannabis reimbursement.

Geoffrey Benic, Aleafia’s CEO, said that this a significant moment in the cannabis sector as well as a huge breakthrough for medical cannabis access in Canada. He explained that the company’s medical team witnesses the benefits of medical cannabis daily in the lives of patients. Benic said that through Aleafia’s reputation in offering premium cannabinoid therapy and Unifor’s progressive leaderships they will expand the medical cannabis benefits to union members nationwide.

Aleafia to sell BLLDR cultivars

Aleafia signed an agreement for exclusive rights to sell Robes Cannabis’ (dba BLLRDR)portfolio of highly-sought-after, rare cannabis cultivars, and other products in the medical cannabis market in Canada. The two highly sought-after cultivars include Wedding Cake and the elusive Afghani Bullride are expected to launch to Emblem in 2021. BLLRDR is majority-owned by OVO co-founder Noah “40” Shebib and Max Zavet the co-founder of Emblem. The company has carefully curated both cultivars for their exclusive terpene and cannabinoid profiles that appeal to patients. Interestingly the Afghani Bullrider often exhibits myrcene levels of more than 1% by dried flower weight.

Benic indicated that the partnership with BLLRDR will help the company to broaden its medical cannabis portfolio by offering BLLRDR’s unique and differentiated cultivars directly to patients.

Related Posts

About The Author

Add Comment